K.P. Schalk

716 total citations
11 papers, 460 citations indexed

About

K.P. Schalk is a scholar working on Pathology and Forensic Medicine, Hematology and Oncology. According to data from OpenAlex, K.P. Schalk has authored 11 papers receiving a total of 460 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pathology and Forensic Medicine, 5 papers in Hematology and 3 papers in Oncology. Recurrent topics in K.P. Schalk's work include Lymphoma Diagnosis and Treatment (5 papers), Iron Metabolism and Disorders (4 papers) and Viral-associated cancers and disorders (2 papers). K.P. Schalk is often cited by papers focused on Lymphoma Diagnosis and Treatment (5 papers), Iron Metabolism and Disorders (4 papers) and Viral-associated cancers and disorders (2 papers). K.P. Schalk collaborates with scholars based in Germany, Italy and United Kingdom. K.P. Schalk's co-authors include J. P. Kaltwasser, René Gottschalk, E. Werner, Christian Seidl, Mario Cazzola, E Ascari, Giovanni Barosi, Mathias Rummel, D. Hoelzer and Ulrich von Gruenhagen and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Gut.

In The Last Decade

K.P. Schalk

11 papers receiving 436 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K.P. Schalk Germany 9 268 243 145 138 82 11 460
M Laulicht United Kingdom 9 298 1.1× 356 1.5× 53 0.4× 124 0.9× 15 0.2× 12 539
Sung‐Soo Yoon South Korea 12 67 0.3× 133 0.5× 56 0.4× 28 0.2× 96 1.2× 42 364
J. Ellegaard Denmark 9 388 1.4× 409 1.7× 21 0.1× 84 0.6× 13 0.2× 14 498
Zhixiang Shen China 11 97 0.4× 128 0.5× 80 0.6× 14 0.1× 102 1.2× 38 386
Daniele Compagnone Germany 8 58 0.2× 185 0.8× 56 0.4× 11 0.1× 18 0.2× 11 512
Franck Lellouche France 8 133 0.5× 194 0.8× 18 0.1× 28 0.2× 10 0.1× 25 348
V. A. Lovric Australia 12 52 0.2× 87 0.4× 36 0.2× 41 0.3× 14 0.2× 37 355
Laïla Zahed Lebanon 13 112 0.4× 125 0.5× 47 0.3× 31 0.2× 28 0.3× 20 493
Mohamed El‐Shanshory Egypt 11 106 0.4× 99 0.4× 21 0.1× 14 0.1× 83 1.0× 41 399
Kristina Tortorelli United States 7 117 0.4× 186 0.8× 62 0.4× 79 0.6× 11 0.1× 9 663

Countries citing papers authored by K.P. Schalk

Since Specialization
Citations

This map shows the geographic impact of K.P. Schalk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K.P. Schalk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K.P. Schalk more than expected).

Fields of papers citing papers by K.P. Schalk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K.P. Schalk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K.P. Schalk. The network helps show where K.P. Schalk may publish in the future.

Co-authorship network of co-authors of K.P. Schalk

This figure shows the co-authorship network connecting the top 25 collaborators of K.P. Schalk. A scholar is included among the top collaborators of K.P. Schalk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K.P. Schalk. K.P. Schalk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
2.
Rummel, Mathias, J. Atta, Manfred Welslau, et al.. (2007). Bendamustine and rituximab (BR) are effective in the treatment of relapsed or refractory indolent and mantle-cell lymphomas: Long-term follow-up of a phase II study. Journal of Clinical Oncology. 25(18_suppl). 8034–8034. 13 indexed citations
3.
Rummel, Mathias, Kai Uwe Chow, T. Karakas, et al.. (2002). Reduced-dose cladribine (2-CdA) plus mitoxantrone is effective in the treatment of mantle-cell and low-grade non-Hodgkin's lymphoma. European Journal of Cancer. 38(13). 1739–1746. 35 indexed citations
4.
Kaltwasser, J. P., et al.. (1998). Clinical trial on the effect of regular tea drinking on iron accumulation in genetic haemochromatosis. Gut. 43(5). 699–704. 79 indexed citations
5.
6.
Steinke, B., H.-M. Reinold, Manfred Heim, et al.. (1992). Cyclic alternating chemotherapy of high-grade malignant non-Hodgkin lymphomas with VIM-Bleo and CHOP. European Journal of Cancer. 28(1). 100–104. 5 indexed citations
7.
Kaltwasser, J. P., et al.. (1990). Non‐invasive quantitation of liver iron‐overload by magnetic resonance imaging. British Journal of Haematology. 74(3). 360–363. 128 indexed citations
8.
Schalk, K.P., et al.. (1989). Tumorerkennung im Serum durch NMR-Spektrometrie. Oncology Research and Treatment. 12(1). 5–8. 1 indexed citations
9.
Kaltwasser, J. P., K.P. Schalk, & E. Werner. (1988). Juvenile Hemochromatosis. Annals of the New York Academy of Sciences. 526(1). 339–341. 10 indexed citations
10.
Kaltwasser, J. P., et al.. (1988). Effect of androgens on the response to antithymocyte globulin in patients with aplastic anaemia. European Journal Of Haematology. 40(2). 111–118. 16 indexed citations
11.
Cazzola, Mario, E Ascari, Giovanni Barosi, et al.. (1983). Juvenile idiopathic haemochromatosis: A life-threatening disorder presenting as hypogonadotropic hypogonadism. Human Genetics. 65(2). 149–154. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M Laulicht Breakdown of academic impact, for papers by Sung‐Soo Yoon Breakdown of academic impact, for papers by J. Ellegaard Breakdown of academic impact, for papers by Zhixiang Shen Breakdown of academic impact, for papers by Daniele Compagnone Breakdown of academic impact, for papers by Franck Lellouche Breakdown of academic impact, for papers by V. A. Lovric Breakdown of academic impact, for papers by Laïla Zahed Breakdown of academic impact, for papers by Mohamed El‐Shanshory Breakdown of academic impact, for papers by Kristina Tortorelli
Rankless by CCL
2026